1. Home
  2. COHU vs TSHA Comparison

COHU vs TSHA Comparison

Compare COHU & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$32.18

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$4.39

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
TSHA
Founded
1947
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
COHU
TSHA
Price
$32.18
$4.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$34.00
$10.78
AVG Volume (30 Days)
517.7K
2.7M
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.56
EPS
N/A
N/A
Revenue
$452,956,000.00
$9,773,000.00
Revenue This Year
$14.38
N/A
Revenue Next Year
$19.12
$1,228.40
P/E Ratio
N/A
N/A
Revenue Growth
12.74
17.28
52 Week Low
$12.80
$1.13
52 Week High
$34.96
$6.02

Technical Indicators

Market Signals
Indicator
COHU
TSHA
Relative Strength Index (RSI) 58.79 47.99
Support Level $27.53 $4.33
Resistance Level $34.96 $5.31
Average True Range (ATR) 1.72 0.26
MACD 0.22 -0.00
Stochastic Oscillator 86.75 53.97

Price Performance

Historical Comparison
COHU
TSHA

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: